Michael Martin Breen
Director, GT Biopharma, Inc.
Companies
- GT Biopharma, Inc.Chief executive officer Jul 19, 2022 to now1
- GT Biopharma, Inc.Board member Nov 12, 2021 to now2
- GT Biopharma, Inc.Chair Jul 19, 2022 to Aug 15, 20231
- Wizard EntertainmentBoard member May 5, 2023 to May 5, 20233
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- GT Biopharma, Inc. GTBP856,218 shares4$6.3M at $7.36Aug 11, 2023
Wizard Entertainment PROP1,144,683 shares5$410.9K at $0.36May 3, 2023
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 11, 2023Granted 200,000 shares at $0.29 of GT Biopharma, Inc.4
- May 3, 2023Granted 218,571 shares at $0.18 of Wizard Entertainment5
- May 3, 2023Bought 916,112 shares at $0.11 of Wizard Entertainment5
- Apr 11, 2023Bought 50,000 shares at $0.50 of GT Biopharma, Inc.6
- Jul 15, 2022Granted 278,058 shares of GT Biopharma, Inc.7
- Feb 25, 2021Converted 9,859 shares at $3.40 of GT Biopharma, Inc.8
- Feb 25, 2021Converted 40,243 shares at $3.40 of GT Biopharma, Inc.8
- Feb 16, 2021Granted 278,058 shares of GT Biopharma, Inc.8
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2SEC EDGARGT Biopharma, Inc., Board member
- 3SEC EDGARWizard Entertainment, Board member
- 4
- 5
- 6SEC EDGARForm 4 filed Apr 11, 2023
- 7SEC EDGARForm 4 filed Jul 19, 2022
- 8SEC EDGARForm 4 filed Nov 12, 2021